News & Updates

PPIs an effective prophylactic agent for stress ulcer

12 Mar 2020

Stress ulcer prophylaxis cuts the risk of bleeding without increasing the incidence of adverse drug events, with proton pump inhibitors (PPIs) seemingly the most effective prophylactic agent, as shown in the results of a systematic review and meta-analysis.

PPIs an effective prophylactic agent for stress ulcer

12 Mar 2020

Heart failure programmes reduce hospitalizations

12 Mar 2020

Heart failure (HF) programmes designed to optimize delivery of guideline-recommended care and provide self-care support to patients have been shown to reduce hospitalizations.

Heart failure programmes reduce hospitalizations

12 Mar 2020

Guideline-directed medical therapy underused in elderly HF patients

12 Mar 2020

Guideline-directed medical therapy (GDMT) is underused in elderly patients with heart failure with reduced ejection fraction (HFrEF), registry data have shown.

Guideline-directed medical therapy underused in elderly HF patients

12 Mar 2020

Dealing with feedback – both in the workplace and online

12 Mar 2020

Doctors are subject to more feedback and scrutiny than ever before, both in the workplace and increasingly, in the public sphere.

Dealing with feedback – both in the workplace and online

12 Mar 2020

Early initiation of sacubitril/valsartan associated with better outcomes in heart failure

12 Mar 2020

In patients with heart failure with reduced ejection fraction (HFrEF) hospitalized for acute decompensated HF (ADHF) who have achieved haemodynamic stability, early in-hospital initiation of the angiotensin receptor-neprilysin inhibitor (ARNI) sacubitril/valsartan is associated with a significant reduction in HF rehospitalization or cardiovascular (CV) death compared with delayed initiation of sacubitril/valsartan after 8 weeks of enalapril treatment, a secondary analysis of the PIONEER-HF trial has shown.

Early initiation of sacubitril/valsartan associated with better outcomes in heart failure

12 Mar 2020

Neonatal Hypoglycaemia – What’s Known and What’s New

12 Mar 2020 by

Hypoglycaemia is one of the most common clinical issues facing newborn babies. It can be caused by abnormalities in the glycogen stores, alternative substrates, and/or functioning enzymes. The definition of neonatal hypoglycaemia itself remains challenging. Understanding normal glucose physiology and biochemistry is important so that the neonatologist can initiate appropriate investigations to elucidate an aetiology and institute correct management. Early diagnosis and prompt treatment of hypoglycaemia will reduce the risk of brain injury to the developing child.

Neonatal Hypoglycaemia – What’s Known and What’s New

12 Mar 2020

CheckMate 214: Nivolumab + ipilimumab benefit maintained at 42 months in aRCC

12 Mar 2020 by

Improvements in overall survival (OS) and clinical responses were maintained with the nivolumab (NIVO) + ipilimumab (IPI) combination in patients with advanced renal cell carcinoma (aRCC) at an extended 42-month follow-up, according to updated results of the CheckMate 214* study presented at ASCO GU 2020.

CheckMate 214: Nivolumab + ipilimumab benefit maintained at 42 months in aRCC

12 Mar 2020

Single long stent on par with multiple overlapping stents for treating diffuse CAD

11 Mar 2020 by

Using a single long 48 mm drug-eluting stent (DES) is comparable to two overlapping DES in terms of target lesion failure (TLF) in patients who had diffuse coronary artery disease (CAD) with very long lesions, according to a Singapore study.

Single long stent on par with multiple overlapping stents for treating diffuse CAD

11 Mar 2020

Advanced adenomas, large serrated polyps predict CRC risk after endoscopy

11 Mar 2020

Patients with advanced adenomas and large serrated polyps on initial endoscopy are at greater risk of colorectal cancer (CRC) and may benefit from more intensive surveillance, a recent study has found.

Advanced adenomas, large serrated polyps predict CRC risk after endoscopy

11 Mar 2020

Middle-aged men with type 2 diabetes at heightened risk of pancreatic cancer

11 Mar 2020

Middle-aged men who have type 2 diabetes have an excess risk of pancreatic cancer, according to a study, suggesting that this population may be potential candidates for cancer screening.

Middle-aged men with type 2 diabetes at heightened risk of pancreatic cancer

11 Mar 2020

News & Updates

Filter by Specialty:

Specialty:

PPIs an effective prophylactic agent for stress ulcer

PPIs an effective prophylactic agent for stress ulcer

Heart failure programmes reduce hospitalizations

Heart failure programmes reduce hospitalizations

Guideline-directed medical therapy underused in elderly HF patients

Guideline-directed medical therapy underused in elderly HF patients

Dealing with feedback – both in the workplace and online

Dealing with feedback – both in the workplace and online

Early initiation of sacubitril/valsartan associated with better outcomes in heart failure

Early initiation of sacubitril/valsartan associated with better outcomes in heart failure

Neonatal Hypoglycaemia – What’s Known and What’s New

Neonatal Hypoglycaemia – What’s Known and What’s New

CheckMate 214: Nivolumab + ipilimumab benefit maintained at 42 months in aRCC

CheckMate 214: Nivolumab + ipilimumab benefit maintained at 42 months in aRCC

Single long stent on par with multiple overlapping stents for treating diffuse CAD

Single long stent on par with multiple overlapping stents for treating diffuse CAD

Advanced adenomas, large serrated polyps predict CRC risk after endoscopy

Advanced adenomas, large serrated polyps predict CRC risk after endoscopy

Middle-aged men with type 2 diabetes at heightened risk of pancreatic cancer

Middle-aged men with type 2 diabetes at heightened risk of pancreatic cancer